Page last updated: 2024-11-04

gatifloxacin and Cystitis

gatifloxacin has been researched along with Cystitis in 2 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Cystitis: Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.

Research Excerpts

ExcerptRelevanceReference
"To investigate the efficacy and safety of gatifloxacin (400mg/day) on chronic prostatitis or cystitis, 453 patients with prostatitis (NIH category II or IIIa) (N=149, mean 45."3.73Efficacy and safety of gatifloxacin for urinary tract infection in nonspecialized Korean urologic practice. ( Cho, IR; Cho, YH; Choo, MS; Hwang, TK; Kim, CI; Kim, CS; Kim, ME; Kim, MH; Kim, YG; Lee, KS; Lee, SD; Lee, SJ; Rhew, HY; Ryu, SB; Shim, BS; Sung, LH; Yoon, DK, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, S1
Akiyama, K1
Yoshimoto, T1
Kanokogi, M1
Yabumoto, H1
Ihara, H1
Ishikawa, E1
Yoshioka, M1
Kokura, K1
Shima, H1
Lee, SD1
Lee, SJ1
Hwang, TK1
Yoon, DK1
Lee, KS1
Sung, LH1
Choo, MS1
Shim, BS1
Cho, IR1
Kim, ME1
Ryu, SB1
Kim, CS1
Kim, YG1
Kim, CI1
Rhew, HY1
Kim, MH1
Cho, YH1

Other Studies

2 other studies available for gatifloxacin and Cystitis

ArticleYear
Clinical efficacy of oral administration of 200 mg gatifloxacin once daily for 3 days for the treatment of patients with uncomplicated cystitis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:2

    Topics: Adult; Anti-Infective Agents; Cystitis; Drug Administration Schedule; Female; Fluoroquinolones; Gati

2009
Efficacy and safety of gatifloxacin for urinary tract infection in nonspecialized Korean urologic practice.
    International journal of antimicrobial agents, 2006, Volume: 28 Suppl 1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cystitis; Female; Fluoroquinolones; Gatifloxacin; Humans

2006